يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Güncan, Sabri"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    دورية أكاديمية

    المساهمون: 2495627

    العلاقة: European urology focus; Tural D., Ölmez Ö. F. , Sümbül A. T. , Artaç M., Özhan N., Akar E., Çakar B., Köstek O., Ekenel M., Erman M., et al., "Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.", European urology focus, 2020; av_193c1701-ea07-4697-9c71-3ce1ad4724fa; vv_1032021; http://hdl.handle.net/20.500.12627/3343Test; https://doi.org/10.1016/j.euf.2020.09.010Test

  4. 4
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: European Urology Focus; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Tural, D., Ölmez, Ö. F., Sümbül, A.T., Artaç, M., Özhan, N., Akar, E. . Kılıçkap, S. (2021). Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences. European Urology Focus, 7(5), 1061-1066. https://dx.doi.org/10.1016/j.euf.2020.09.010Test; https://dx.doi.org/10.1016/j.euf.2020.09.010Test; https://hdl.handle.net/20.500.12511/8685Test; 1061; 1066; Q1

  5. 5
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: International Journal of Clinical Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Tural, D., Ölmez, Ö. F., Sümbül, A. T., Özhan, N., Çakar, B., Köstek, O. . Artaç, M. (2021). Prognostic factors in patients with metastatic urothelial carcinoma who have treated with atezolizumab. International Journal of Clinical Oncology, 26(8), 1506-1513. https://dx.doi.org/10.1007/s10147-021-01936-6Test; https://dx.doi.org/10.1007/s10147-021-01936-6Test; https://hdl.handle.net/20.500.12511/8504Test; 26; 1506; 1513; Q3; Q1

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
  10. 10
    دورية أكاديمية